Alemtuzumab plus CHOP versus CHOP in elderly patients with peripheral T-cell lymphoma: the DSHNHL2006-1B/ACT-2 trial

for the ACT-2 study investigators, Gerald Wulf, Bettina Altmann, Marita Ziepert, Francesco d’Amore, Gerhard Held, Richard Greil, Olivier Tournilhac, Thomas Relander, Andreas Viardot, Martin Wilhelm, Christian Wilhelm, Antonio Pezzutto, Josée M. Zijlstra, Éric Van Den Neste, Pieternella J. Lugtenburg, Jeanette K. Doorduijn, Michel van Gelder, Gustaaf W. van Imhoff, Florian Zettl, Friederike Braulke, Maike Nickelsen, Bertram Glaß, Andreas Rosenwald, Philippe Gaulard, Markus Loeffler, Michael Pfreundschuh, Norbert Schmitz, Lorenz Trümper